These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20094738)

  • 1. Oxidative stress and plasma aminopeptidase activity in Huntington's disease.
    Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
    J Neural Transm (Vienna); 2010 Mar; 117(3):325-32. PubMed ID: 20094738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.
    Klepac N; Relja M; Klepac R; Hećimović S; Babić T; Trkulja V
    J Neurol; 2007 Dec; 254(12):1676-83. PubMed ID: 17990062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment.
    Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
    Neurodegener Dis; 2011; 8(3):109-16. PubMed ID: 20714110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
    Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
    Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
    Chen CM; Wu YR; Cheng ML; Liu JL; Lee YM; Lee PW; Soong BW; Chiu DT
    Biochem Biophys Res Commun; 2007 Jul; 359(2):335-40. PubMed ID: 17543886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease.
    Ciammola A; Sassone J; Sciacco M; Mencacci NE; Ripolone M; Bizzi C; Colciago C; Moggio M; Parati G; Silani V; Malfatto G
    Mov Disord; 2011 Jan; 26(1):130-7. PubMed ID: 20931633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
    Stoy N; Mackay GM; Forrest CM; Christofides J; Egerton M; Stone TW; Darlington LG
    J Neurochem; 2005 May; 93(3):611-23. PubMed ID: 15836620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers.
    Silva AC; Almeida S; Laço M; Duarte AI; Domingues J; Oliveira CR; Januário C; Rego AC
    Mitochondrion; 2013 Nov; 13(6):801-9. PubMed ID: 23707479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Oxidative Stress Marker Aberrations in Patients with Huntington's Disease: A Meta-Analysis Study.
    Tang Q; Liu H; Shi XJ; Cheng Y
    Oxid Med Cell Longev; 2020; 2020():9187195. PubMed ID: 32963705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease.
    Sánchez-López F; Tasset I; Agüera E; Feijóo M; Fernández-Bolaños R; Sánchez FM; Ruiz MC; Cruz AH; Gascón F; Túnez I
    Neurol Res; 2012 Sep; 34(7):721-4. PubMed ID: 22889672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
    Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
    J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
    Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
    Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female Sexual Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington's Disease.
    Kolenc M; Kobal J; Podnar S
    J Huntingtons Dis; 2017; 6(2):105-113. PubMed ID: 28482643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral biomarkers of oxidative stress and their limited potential in evaluation of clinical features of Huntington's patients.
    Ciancarelli I; De Amicis D; Di Massimo C; Di Scanno C; Pistarini C; D'Orazio N; Tozzi Ciancarelli MG
    Biomarkers; 2014 Sep; 19(6):452-6. PubMed ID: 24980251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes.
    Machiela E; Dues DJ; Senchuk MM; Van Raamsdonk JM
    Neurobiol Dis; 2016 Dec; 96():1-11. PubMed ID: 27544481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease.
    Tobore TO
    J Neurosci Res; 2019 Nov; 97(11):1455-1468. PubMed ID: 31304621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.
    Chang KH; Wu YR; Chen YC; Chen CM
    Brain Behav Immun; 2015 Feb; 44():121-7. PubMed ID: 25266150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.
    Saft C; Zange J; Andrich J; Müller K; Lindenberg K; Landwehrmeyer B; Vorgerd M; Kraus PH; Przuntek H; Schöls L
    Mov Disord; 2005 Jun; 20(6):674-9. PubMed ID: 15704211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional MRI signal fluctuations highlight altered resting brain activity in Huntington's disease.
    Sarappa C; Salvatore E; Filla A; Cocozza S; Russo CV; Saccà F; Brunetti A; De Michele G; Quarantelli M
    Brain Imaging Behav; 2017 Oct; 11(5):1459-1469. PubMed ID: 27734308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.